NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Amaroq Therapeutics

Amaroq Therapeutics

Private
DunedinHealthcare & Life Scienceshttps://www.amaroqtx.com/

Last Round

Seed

Jul 8, 2021

Total Funding Raised

$9.7M

Company Overview

Amaroq Therapeutics is a biotechnology company that develops cancer therapeutics targeting long non-coding RNA.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

lncRNA therapeuticslong non-coding RNAlncRNAAI drug discoverydrug discovery platformprecision oncologyRNA therapeuticsfirst-in-class therapiesgenomic dark mattertarget identificationcomputational genomicscancer therapeuticspharmaceutical partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amaroq Therapeutics Comparables

Compare Amaroq Therapeutics with similar companies based on industry and business-model similarity.

Amaroq Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Flamingo Therapeutics
88%
NextRNA Therapeutics
86%
水木星辰生物制药(深圳)有限公司
81%

Amaroq Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 8, 2021

Amaroq Therapeutics Investors

Notable investors and investment history

Amaroq Therapeutics investors
InvestorRounds
Otago Innovation LtdSeed
Cure Kids VenturesSeed
BoosterSeed
Brandon CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2024

    Monthly visitors increased 45% MoM.

  • Jul 8, 2021

    $9.7M round led by Brandon Capital

Amaroq Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amaroq Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amaroq Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDunedin
Employee Range7
Year Founded2021
Last FundingJul 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.